Dr. Camile A. Gooden-Bost, MD

Dr. Gooden-Bost practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Gooden-Bost's NPI, 1992092365, was assigned on July 6, 2011. Dr. Gooden-Bost graduated from Uconn School Of Medicine in 2010. Dr. Gooden-Bost holds New York license 270257.

Dr. Gooden-Bost's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-3130.

Dr. Gooden-Bost's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Gooden-Bost is also affiliated with Stony Brook University Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Gooden-Bost to 1 more hospital, 2 group practices and clinics, 2 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gooden-Bost practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gooden-Bost's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gooden-Bost is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gooden-Bost is licensed in New York.

Dmand AI lists acid reflux, acute kidney failure, acute mini-stroke (TIA), acute respiratory failure, acute sinusitis, acute skin infection, anemia and aneurysm among the conditions Dr. Gooden-Bost treats.

CMS data shows 1,062 Medicare services from Dr. Gooden-Bost across 8 procedure codes in 2024, for 279 Medicare patients. Medicare paid $79,126 for them. Every service was in an office.

CMS counts 279 Medicare patients who saw Dr. Gooden-Bost in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gooden-Bost's median patient age at 65, with 78% women.

In 2024, Dr. Gooden-Bost wrote 3,915 Medicare Part D claims for 495 patients. 90% of them were for generic drugs. CMS names the drug for 3,347 of them, across 87 drugs with 11 or more claims each, at $259,735 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gooden-Bost for performance year 2024, reported as part of a group. Dr. Gooden-Bost accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gooden-Bost as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Gooden-Bost from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $150.

Dr. Gooden-Bost graduated from Uconn School Of Medicine in 2010. Dr. Gooden-Bost is a member of AAPL, American Board of Quality Assurance and Utilization Review Physicians, American College of Physician Advisors, ACP and AMA.

Dr. Gooden-Bost is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.